These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785 [TBL] [Abstract][Full Text] [Related]
4. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Merched AJ; Williams E; Chan L Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1608-14. PubMed ID: 12842843 [TBL] [Abstract][Full Text] [Related]
5. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027 [TBL] [Abstract][Full Text] [Related]
7. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908 [TBL] [Abstract][Full Text] [Related]
8. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Guevara NV; Kim HS; Antonova EI; Chan L Nat Med; 1999 Mar; 5(3):335-9. PubMed ID: 10086392 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II amplifies macrophage-driven atherosclerosis. Nobuhiko A; Suganuma E; Babaev VR; Fogo A; Swift LL; Linton MF; Fazio S; Ichikawa I; Kon V Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2143-8. PubMed ID: 15374850 [TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice. Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414 [TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650 [TBL] [Abstract][Full Text] [Related]
12. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373 [TBL] [Abstract][Full Text] [Related]
13. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice. Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561 [TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151 [TBL] [Abstract][Full Text] [Related]
15. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Foteinos G; Hu Y; Xiao Q; Metzler B; Xu Q Circulation; 2008 Apr; 117(14):1856-63. PubMed ID: 18378610 [TBL] [Abstract][Full Text] [Related]
16. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Wong CW; Christen T; Roth I; Chadjichristos CE; Derouette JP; Foglia BF; Chanson M; Goodenough DA; Kwak BR Nat Med; 2006 Aug; 12(8):950-4. PubMed ID: 16862155 [TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice. Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559 [TBL] [Abstract][Full Text] [Related]
19. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335 [TBL] [Abstract][Full Text] [Related]
20. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]